LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 67.41 | 84.90 | 7540 | 8766 | 0.8601 | 0.9555 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 69.11 | 84.90 | 3 | 8988 | 0.0003 | -0.3916 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 69.11 | 84.90 | 4374 | 8988 | 0.4867 | 0.7969 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 69.11 | 84.90 | 959 | 8988 | 0.1067 | 0.4340 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 69.11 | 84.90 | 7827 | 8988 | 0.8708 | 0.9593 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 70.81 | 84.90 | 6 | 9132 | 0.0007 | -0.3247 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 70.81 | 84.90 | 4596 | 9132 | 0.5033 | 0.8065 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 70.81 | 84.90 | 916 | 9132 | 0.1003 | 0.4225 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 70.81 | 84.90 | 8089 | 9132 | 0.8858 | 0.9644 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 72.52 | 84.90 | 7 | 9214 | 0.0008 | -0.3086 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 72.52 | 84.90 | 4572 | 9214 | 0.4962 | 0.8031 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 72.52 | 84.90 | 967 | 9214 | 0.1049 | 0.4330 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 72.52 | 84.90 | 8377 | 9214 | 0.9091 | 0.9720 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 74.22 | 84.90 | 1 | 9343 | 0.0001 | -0.4805 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 74.22 | 84.90 | 4657 | 9343 | 0.4984 | 0.8049 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 74.22 | 84.90 | 926 | 9343 | 0.0991 | 0.4224 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 74.22 | 84.90 | 8566 | 9343 | 0.9168 | 0.9745 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 75.93 | 84.90 | 2 | 8970 | 0.0002 | -0.4274 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 75.93 | 84.90 | 4758 | 8970 | 0.5304 | 0.8200 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 75.93 | 84.90 | 920 | 8970 | 0.1026 | 0.4254 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 75.93 | 84.90 | 8801 | 8970 | 0.9811 | 0.9943 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 77.64 | 84.90 | 7 | 9245 | 0.0008 | -0.3084 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 77.64 | 84.90 | 4939 | 9245 | 0.5342 | 0.8230 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 77.64 | 84.90 | 878 | 9245 | 0.0950 | 0.4123 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 77.64 | 84.90 | 9054 | 9245 | 0.9793 | 0.9938 | MN20160318_Q02 | I20 |